
LINK . SPRINGER . COM {
}
Title:
TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer | Journal of Translational Medicine
Description:
Background Impairment of natural killer (NK) cell activity is an important mechanism of tumor immunoevasion. T cell immunoglobulin domain and mucin domain-3 (Tim-3) is an activation-induced inhibitory molecule, inducing effector lymphocyte exhaustion in chronic viral infection and cancers. However, its function in NK cells in human esophageal cancer remains unclear. Methods We prospectively collected peripheral blood and tumor samples from 53 patients with esophageal cancer. Peripheral and tumor-infiltrating NK cells were analyzed for Tim-3, Annexin V, CD69, CD107a and IFN-γ expression by flow cytometry. Quantitative real-time PCR was used to test relative mRNA expression of IFN-γ, granzyme B, perforin and NKG2D in sorted Tim-3+ NK cells and Tim-3− NK cells, respectively. NK cells isolated from healthy donors were treated with recombinant TNF-α to induce Tim-3 expression. Tim-3 and TNF-α mRNA levels in tumor tissues were measured in both humans and mice. Finally, associations between NK cell frequencies with pathological parameters were investigated. Results We observed up-regulation of Tim-3 expression on NK cells from esophageal cancer patients, especially at the tumor site. Furthermore, tumor-infiltrating NK cells with high Tim-3 expression exhibited a phenotype with enhanced dysfunction. In vitro, Tim-3 expression on NK cells isolated from blood of healthy donors can be induced by recombinant TNF-α via NF-κB pathway. In both animal models and patients, the Tim-3 level was positively correlated with TNF-α expression in esophageal cancer tissues. Finally, higher Tim-3 level on tumor-infiltrating NK cells is correlated with tumor invasion, nodal status and poor stage in patients with esophageal cancer. Conclusions Taken together, Tim-3 may play a crucial role to induce NK cell dysfunction in tumor microenvironment and could serve as a potential biomarker for prognosis of esophageal cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be cashing in, but we can't detect the method they're using.
Keywords {🔍}
cells, tim, cancer, esophageal, expression, article, patients, tumor, tnfα, cell, google, scholar, fig, human, cas, tissues, significant, tumorinfiltrating, til, flow, mice, immune, analysis, data, peripheral, immunol, dysfunction, natural, nfκb, microenvironment, pbmc, killer, functions, subsets, healthy, levels, prognosis, inhibitor, exhaustion, blood, ifnγ, cytometry, results, frequency, donors, pathological, poor, lymphocytes, surface, reported,
Topics {✒️}
tumour necrosis factor tumor necrosis factor-α blocking pd-1/pd-l1 signaling suppresses cell-mediated cytotoxicity nf-κb signaling pathway reducing t-cell responses regulating anti-tumor immunity fluorochrome-conjugated primary antibodies translational medicine aims restoring anti-tumor activity t-cell immunoglobulin domain tnf-α mrna levels recombinant human tnf-α 4nqo-induced esophageal lesions cancer-related death worldwide modified gt-t551 medium 4-nqo-induced animal model step qrt-pcr kit tumor-infiltrating nk cells carcinogen-induced esophageal cancer recombinant human tgf-β enhance ifn-γ production article download pdf suppress ifn-γ production quantitative real-time pcr activation-induced inhibitory molecule 5 ng/ml tnf-α added tnf-α inhibitor nf-κb inhibitor cd3−cd56dim nk cells nf-κb pathway determined tnf-α level examined ifn-γ production tnf-α leads relative mrna levels nk cells cultured nf-κb cascade nf-κb mediates blocking tim-3 signaling privacy choices/manage cookies inhibitory molecule expressed cell immunoglobulin domain examined mrna levels squamous cell carcinoma gm-csf article 28 nk cell death human esophageal cancer infiltrating nk cells early research suggests primary esophageal cancer
Schema {🗺️}
WebPage:
mainEntity:
headline:TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer
description:Impairment of natural killer (NK) cell activity is an important mechanism of tumor immunoevasion. T cell immunoglobulin domain and mucin domain-3 (Tim-3) is an activation-induced inhibitory molecule, inducing effector lymphocyte exhaustion in chronic viral infection and cancers. However, its function in NK cells in human esophageal cancer remains unclear. We prospectively collected peripheral blood and tumor samples from 53 patients with esophageal cancer. Peripheral and tumor-infiltrating NK cells were analyzed for Tim-3, Annexin V, CD69, CD107a and IFN-γ expression by flow cytometry. Quantitative real-time PCR was used to test relative mRNA expression of IFN-γ, granzyme B, perforin and NKG2D in sorted Tim-3+ NK cells and Tim-3− NK cells, respectively. NK cells isolated from healthy donors were treated with recombinant TNF-α to induce Tim-3 expression. Tim-3 and TNF-α mRNA levels in tumor tissues were measured in both humans and mice. Finally, associations between NK cell frequencies with pathological parameters were investigated. We observed up-regulation of Tim-3 expression on NK cells from esophageal cancer patients, especially at the tumor site. Furthermore, tumor-infiltrating NK cells with high Tim-3 expression exhibited a phenotype with enhanced dysfunction. In vitro, Tim-3 expression on NK cells isolated from blood of healthy donors can be induced by recombinant TNF-α via NF-κB pathway. In both animal models and patients, the Tim-3 level was positively correlated with TNF-α expression in esophageal cancer tissues. Finally, higher Tim-3 level on tumor-infiltrating NK cells is correlated with tumor invasion, nodal status and poor stage in patients with esophageal cancer. Taken together, Tim-3 may play a crucial role to induce NK cell dysfunction in tumor microenvironment and could serve as a potential biomarker for prognosis of esophageal cancer.
datePublished:2019-05-20T00:00:00Z
dateModified:2019-05-20T00:00:00Z
pageStart:1
pageEnd:12
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12967-019-1917-0
keywords:
Tumor microenvironment
NK cells
Tim-3
TNF-α
Esophageal cancer
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig6_HTML.png
isPartOf:
name:Journal of Translational Medicine
issn:
1479-5876
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Yujia Zheng
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jingyao Lian
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Huiyun Yang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Feng Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Song Zhao
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu Qi
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yi Zhang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Lan Huang
url:http://orcid.org/0000-0001-6556-4067
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer
description:Impairment of natural killer (NK) cell activity is an important mechanism of tumor immunoevasion. T cell immunoglobulin domain and mucin domain-3 (Tim-3) is an activation-induced inhibitory molecule, inducing effector lymphocyte exhaustion in chronic viral infection and cancers. However, its function in NK cells in human esophageal cancer remains unclear. We prospectively collected peripheral blood and tumor samples from 53 patients with esophageal cancer. Peripheral and tumor-infiltrating NK cells were analyzed for Tim-3, Annexin V, CD69, CD107a and IFN-γ expression by flow cytometry. Quantitative real-time PCR was used to test relative mRNA expression of IFN-γ, granzyme B, perforin and NKG2D in sorted Tim-3+ NK cells and Tim-3− NK cells, respectively. NK cells isolated from healthy donors were treated with recombinant TNF-α to induce Tim-3 expression. Tim-3 and TNF-α mRNA levels in tumor tissues were measured in both humans and mice. Finally, associations between NK cell frequencies with pathological parameters were investigated. We observed up-regulation of Tim-3 expression on NK cells from esophageal cancer patients, especially at the tumor site. Furthermore, tumor-infiltrating NK cells with high Tim-3 expression exhibited a phenotype with enhanced dysfunction. In vitro, Tim-3 expression on NK cells isolated from blood of healthy donors can be induced by recombinant TNF-α via NF-κB pathway. In both animal models and patients, the Tim-3 level was positively correlated with TNF-α expression in esophageal cancer tissues. Finally, higher Tim-3 level on tumor-infiltrating NK cells is correlated with tumor invasion, nodal status and poor stage in patients with esophageal cancer. Taken together, Tim-3 may play a crucial role to induce NK cell dysfunction in tumor microenvironment and could serve as a potential biomarker for prognosis of esophageal cancer.
datePublished:2019-05-20T00:00:00Z
dateModified:2019-05-20T00:00:00Z
pageStart:1
pageEnd:12
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12967-019-1917-0
keywords:
Tumor microenvironment
NK cells
Tim-3
TNF-α
Esophageal cancer
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_Fig6_HTML.png
isPartOf:
name:Journal of Translational Medicine
issn:
1479-5876
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Yujia Zheng
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Jingyao Lian
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Huiyun Yang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Feng Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Song Zhao
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu Qi
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yi Zhang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
type:Person
name:Lan Huang
url:http://orcid.org/0000-0001-6556-4067
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Journal of Translational Medicine
issn:
1479-5876
volumeNumber:17
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Yujia Zheng
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Yu Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Jingyao Lian
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Huiyun Yang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Feng Li
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Song Zhao
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Yu Qi
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Yi Zhang
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
name:Lan Huang
url:http://orcid.org/0000-0001-6556-4067
affiliation:
name:The First Affiliated Hospital, Zhengzhou University
address:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
name:Biotherapy Center, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
External Links {🔗}(132)
- How much does https://www.springernature.com/gp/authors pull in monthly?
- How much does https://link.springernature.com/home/ pull in?
- What's the monthly money flow for https://order.springer.com/public/cart?
- How much income does https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research have?
- How much profit is https://translational-medicine.biomedcentral.com/about making per month?
- How much does https://www.editorialmanager.com/jtrm/ rake in every month?
- Explore the financials of https://orcid.org/0000-0001-6556-4067
- Find out how much https://doi.org/10.1136%2Fgutjnl-2017-315520 earns monthly
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20endoscopic%20screening%20for%20esophageal%20cancer%20in%20China%20%28ESECC%29%3A%20design%20and%20preliminary%20results%20of%20a%20population-based%20randomised%20controlled%20trial&journal=Gut.&doi=10.1136%2Fgutjnl-2017-315520&volume=68&pages=198-206&publication_year=2019&author=He%2CZ&author=Liu%2CZ&author=Liu%2CM&author=Guo%2CC&author=Xu%2CR&author=Li%2CF&author=Liu%2CA&author=Yang%2CH&author=Shen%2CL&author=Wu%2CQ
- How much does https://doi.org/10.1053%2Fj.gastro.2017.07.041 generate monthly?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Endoscopic%20management%20of%20early%20adenocarcinoma%20and%20squamous%20cell%20carcinoma%20of%20the%20esophagus%3A%20screening%2C%20diagnosis%2C%20and%20therapy&journal=Gastroenterology&doi=10.1053%2Fj.gastro.2017.07.041&volume=154&pages=421-436&publication_year=2018&author=Pietro%2CM&author=Canto%2CMI&author=Fitzgerald%2CRC?
- Financial intake of https://doi.org/10.1038%2Fcddis.2015.162
- Get to know http://scholar.google.com/scholar_lookup?&title=T-cell%20exhaustion%20in%20the%20tumor%20microenvironment&journal=Cell%20Death%20Dis&doi=10.1038%2Fcddis.2015.162&volume=6&publication_year=2015&author=Jiang%2CY&author=Li%2CY&author=Zhu%2CB's earnings
- Earnings of http://scholar.google.com/scholar_lookup?&title=High%20immunosuppressive%20burden%20in%20cancer%20patients%3A%20a%20major%20hurdle%20for%20cancer%20immunotherapy&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-016-1810-0&volume=65&pages=813-819&publication_year=2016&author=Kalathil%2CSG&author=Thanavala%2CY
- Learn about the earnings of https://doi.org/10.1038%2Fncomms15776
- Revenue of http://scholar.google.com/scholar_lookup?&title=IL-21-mediated%20reversal%20of%20NK%20cell%20exhaustion%20facilitates%20anti-tumour%20immunity%20in%20MHC%20class%20I-deficient%20tumours&journal=Nat%20Commun&doi=10.1038%2Fncomms15776&volume=8&publication_year=2017&author=Seo%2CH&author=Jeon%2CI&author=Kim%2CB-S&author=Park%2CM&author=Bae%2CE-A&author=Song%2CB&author=Koh%2CC-H&author=Shin%2CK-S&author=Kim%2CI-K&author=Choi%2CK
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27736796?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342711 make?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20tumor%20infiltrating%20NK%20cells%20and%20macrophages%20in%20stage%20II%E2%80%89%2B%E2%80%89III%20esophageal%20cancer%20patients&journal=Oncotarget&volume=7&pages=74904-74916&publication_year=2016&author=Xu%2CB&author=Chen%2CL&author=Li%2CJ&author=Zheng%2CX&author=Shi%2CL&author=Wu%2CC&author=Jiang%2CJ?
- How much cash flow does https://doi.org/10.1002%2Fijc.29481 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Low%20expression%20of%20Bin1%2C%20along%20with%20high%20expression%20of%20IDO%20in%20tumor%20tissue%20and%20draining%20lymph%20nodes%2C%20are%20predictors%20of%20poor%20prognosis%20for%20esophageal%20squamous%20cell%20cancer%20patients&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.29481&volume=137&pages=1095-1106&publication_year=2015&author=Jia%2CY&author=Wang%2CH&author=Wang%2CY&author=Wang%2CT&author=Wang%2CM&author=Ma%2CM&author=Duan%2CY&author=Meng%2CX&author=Liu%2CL earn?
- How much money does https://doi.org/10.1038%2F38028 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Structure%20of%20the%20inhibitory%20receptor%20for%20human%20natural%20killer%20cells%20resembles%20haematopoietic%20receptors&journal=Nature&doi=10.1038%2F38028&volume=389&pages=96-100&publication_year=1997&author=Fan%2CQR&author=Mosyak%2CL&author=Winter%2CCC&author=Wagtmann%2CN&author=Long%2CEO&author=Wiley%2CDC net monthly?
- How much profit does https://doi.org/10.1158%2F0008-5472.CAN-17-1032 generate?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Restoration%20of%20natural%20killer%20cell%20antimetastatic%20activity%20by%20IL12%20and%20checkpoint%20blockade&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-17-1032&volume=77&pages=7059-7071&publication_year=2017&author=Ohs%2CI&author=Ducimetiere%2CL&author=Marinho%2CJ&author=Kulig%2CP&author=Becher%2CB&author=Tugues%2CS?
- What's the revenue for https://doi.org/10.1038%2Fonc.2017.209?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Increased%20expression%20of%20programmed%20cell%20death%20protein%201%20on%20NK%20cells%20inhibits%20NK-cell-mediated%20anti-tumor%20function%20and%20indicates%20poor%20prognosis%20in%20digestive%20cancers&journal=Oncogene&doi=10.1038%2Fonc.2017.209&volume=36&pages=6143-6153&publication_year=2017&author=Liu%2CY&author=Cheng%2CY&author=Xu%2CY&author=Wang%2CZ&author=Du%2CX&author=Li%2CC&author=Peng%2CJ&author=Gao%2CL&author=Liang%2CX&author=Ma%2CC
- Learn how profitable https://doi.org/10.1016%2Fj.immuni.2016.05.001 is on a monthly basis
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Lag-3%2C%20Tim-3%2C%20and%20TIGIT%3A%20co-inhibitory%20receptors%20with%20specialized%20functions%20in%20immune%20regulation&journal=Immunity&doi=10.1016%2Fj.immuni.2016.05.001&volume=44&pages=989-1004&publication_year=2016&author=Anderson%2CAC&author=Joller%2CN&author=Kuchroo%2CVK?
- Learn about the earnings of https://doi.org/10.1111%2Fimr.12520
- How much income is http://scholar.google.com/scholar_lookup?&title=Tim-3%20and%20its%20role%20in%20regulating%20anti-tumor%20immunity&journal=Immunol%20Rev&doi=10.1111%2Fimr.12520&volume=276&pages=97-111&publication_year=2017&author=Das%2CM&author=Zhu%2CC&author=Kuchroo%2CVK earning monthly?
- How much income does https://doi.org/10.1158%2F0008-5472.CAN-16-0274 have?
- How much does http://scholar.google.com/scholar_lookup?&title=Tim-3%20expression%20on%20tumor-infiltrating%20PD-1%28%2B%29CD8%28%2B%29%20T%20cells%20correlates%20with%20poor%20clinical%20outcome%20in%20renal%20cell%20carcinoma&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-16-0274&volume=77&pages=1075-1082&publication_year=2017&author=Granier%2CC&author=Dariane%2CC&author=Combe%2CP&author=Verkarre%2CV&author=Urien%2CS&author=Badoual%2CC&author=Roussel%2CH&author=Mandavit%2CM&author=Ravel%2CP&author=Sibony%2CM gross monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Antibodies%20against%20immune%20checkpoint%20molecules%20restore%20functions%20of%20tumor-infiltrating%20t%20cells%20in%20hepatocellular%20carcinomas&journal=Gastroenterology&volume=153&issue=1107%E2%80%931119&publication_year=2017&author=Zhou%2CG&author=Sprengers%2CD&author=Boor%2CPPC&author=Doukas%2CM&author=Schutz%2CH&author=Mancham%2CS&author=Pedroza-Gonzalez%2CA&author=Polak%2CWG&author=Jonge%2CJ&author=Gaspersz%2CM?
- Earnings of https://doi.org/10.1111%2Fj.0105-2896.2010.00903.x
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=TIM%20genes%3A%20a%20family%20of%20cell%20surface%20phosphatidylserine%20receptors%20that%20regulate%20innate%20and%20adaptive%20immunity&journal=Immunol%20Rev&doi=10.1111%2Fj.0105-2896.2010.00903.x&volume=235&pages=172-189&publication_year=2010&author=Freeman%2CGJ&author=Casasnovas%2CJM&author=Umetsu%2CDT&author=DeKruyff%2CRH
- Discover the revenue of https://doi.org/10.3389%2Ffimmu.2013.00449
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Tim-3%3A%20an%20activation%20marker%20and%20activation%20limiter%20of%20innate%20immune%20cells&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2013.00449&volume=4&publication_year=2013&author=Han%2CG&author=Chen%2CG&author=Shen%2CB&author=Li%2CY?
- How much revenue does https://doi.org/10.1182%2Fblood-2011-06-360321 generate?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Tim-3%20is%20an%20inducible%20human%20natural%20killer%20cell%20receptor%20that%20enhances%20interferon%20gamma%20production%20in%20response%20to%20galectin-9&journal=Blood&doi=10.1182%2Fblood-2011-06-360321&volume=119&pages=3064-3072&publication_year=2012&author=Gleason%2CMK&author=Lenvik%2CTR&author=McCullar%2CV&author=Felices%2CM&author=O%E2%80%99Brien%2CMS&author=Cooley%2CSA&author=Verneris%2CMR&author=Cichocki%2CF&author=Holman%2CCJ&author=Panoskaltsis-Mortari%2CA?
- What's the income generated by https://doi.org/10.3109%2F08820139.2015.1052145 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20clinical%20significance%20of%20abnormal%20tim-3%20expression%20on%20NK%20cells%20from%20patients%20with%20gastric%20cancer&journal=Immunol%20Invest&doi=10.3109%2F08820139.2015.1052145&volume=44&pages=578-589&publication_year=2015&author=Wang%2CZ&author=Zhu%2CJ&author=Gu%2CH&author=Yuan%2CY&author=Zhang%2CB&author=Zhu%2CD&author=Zhou%2CJ&author=Zhu%2CY&author=Chen%2CW bring in?
- What's the monthly money flow for https://doi.org/10.1016%2Fj.intimp.2015.09.017?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Increased%20Tim-3%20expression%20in%20peripheral%20NK%20cells%20predicts%20a%20poorer%20prognosis%20and%20Tim-3%20blockade%20improves%20NK%20cell-mediated%20cytotoxicity%20in%20human%20lung%20adenocarcinoma&journal=Int%20Immunopharmacol&doi=10.1016%2Fj.intimp.2015.09.017&volume=29&pages=635-641&publication_year=2015&author=Xu%2CL&author=Huang%2CY&author=Tan%2CL&author=Yu%2CW&author=Chen%2CD&author=Lu%2CC&author=He%2CJ&author=Wu%2CG&author=Liu%2CX&author=Zhang%2CY generate?
- How much revenue does https://doi.org/10.1158%2F2326-6066.CIR-13-0171 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Reversal%20of%20NK-cell%20exhaustion%20in%20advanced%20melanoma%20by%20Tim-3%20blockade&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-13-0171&volume=2&pages=410-422&publication_year=2014&author=Silva%2CIP&author=Gallois%2CA&author=Jimenez-Baranda%2CS&author=Khan%2CS&author=Anderson%2CAC&author=Kuchroo%2CVK&author=Osman%2CI&author=Bhardwaj%2CN pull in monthly?
- How much does https://doi.org/10.1111%2Fj.1600-065X.2006.00451.x gross monthly?
- See how much http://scholar.google.com/scholar_lookup?&title=Human%20natural%20killer%20cell%20development&journal=Immunol%20Rev&doi=10.1111%2Fj.1600-065X.2006.00451.x&volume=214&pages=56-72&publication_year=2006&author=Freud%2CAG&author=Caligiuri%2CMA makes per month
- Earnings of https://doi.org/10.1172%2FJCI90387
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=CD56bright%20NK%20cells%20exhibit%20potent%20antitumor%20responses%20following%20IL-15%20priming&journal=J%20Clin%20Invest&doi=10.1172%2FJCI90387&volume=127&pages=4042-4058&publication_year=2017&author=Wagner%2CJA&author=Rosario%2CM&author=Romee%2CR&author=Berrien-Elliott%2CMM&author=Schneider%2CSE&author=Leong%2CJW&author=Sullivan%2CRP&author=Jewell%2CBA&author=Becker-Hapak%2CM&author=Schappe%2CT?
- What's the monthly money flow for https://doi.org/10.1158%2F2326-6066.CIR-14-0201?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=PD-1%E2%80%89%2B%E2%80%89Tim-3%E2%80%89%2B%E2%80%89CD8%E2%80%89%2B%E2%80%89T%20lymphocytes%20display%20varied%20degrees%20of%20functional%20exhaustion%20in%20patients%20with%20regionally%20metastatic%20differentiated%20thyroid%20cancer&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-14-0201&volume=3&pages=620-630&publication_year=2015&author=Severson%2CJJ&author=Serracino%2CHS&author=Mateescu%2CV&author=Raeburn%2CCD&author=McIntyre%2CRC&author=Sams%2CSB&author=Haugen%2CBR&author=French%2CJD produce monthly?
- What's the total monthly financial gain of https://doi.org/10.1038%2Fjid.2013.75?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20T%20cells%20in%20human%20Merkel%20cell%20carcinomas%3A%20a%20possible%20role%20for%20Tregs%20and%20T-cell%20exhaustion%20in%20reducing%20T-cell%20responses&journal=J%20Invest%20Dermatol&doi=10.1038%2Fjid.2013.75&volume=133&pages=1879-1889&publication_year=2013&author=Dowlatshahi%2CM&author=Huang%2CV&author=Gehad%2CAE&author=Jiang%2CY&author=Calarese%2CA&author=Teague%2CJE&author=Dorosario%2CAA&author=Cheng%2CJ&author=Nghiem%2CP&author=Schanbacher%2CCF produce monthly?
- Find out how much https://doi.org/10.1038%2Fnrc2628 earns monthly
- Revenue of http://scholar.google.com/scholar_lookup?&title=Tumour%20necrosis%20factor%20and%20cancer&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2628&volume=9&pages=361-371&publication_year=2009&author=Balkwill%2CF
- What's the revenue for https://doi.org/10.1056%2FNEJMoa031197?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Loss%20of%20Smad3%20in%20acute%20T-cell%20lymphoblastic%20leukemia&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa031197&volume=351&pages=552-559&publication_year=2004&author=Wolfraim%2CLA&author=Fernandez%2CTM&author=Mamura%2CM&author=Fuller%2CWL&author=Kumar%2CR&author=Cole%2CDE&author=Byfield%2CS&author=Felici%2CA&author=Flanders%2CKC&author=Walz%2CTM
- Learn how profitable https://doi.org/10.1136%2Fgutjnl-2014-307671 is on a monthly basis
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Tim-3%20fosters%20HCC%20development%20by%20enhancing%20TGF-beta-mediated%20alternative%20activation%20of%20macrophages&journal=Gut.&doi=10.1136%2Fgutjnl-2014-307671&volume=64&pages=1593-604&publication_year=2015&author=Yan%2CW&author=Liu%2CX&author=Ma%2CH&author=Zhang%2CH&author=Song%2CX&author=Gao%2CL&author=Liang%2CX&author=Ma%2CC bring in?
- How much does https://doi.org/10.1038%2Fs41467-017-02358-7 rake in every month?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=TNFalpha%20blockade%20overcomes%20resistance%20to%20anti-PD-1%20in%20experimental%20melanoma&journal=Nat%20Commun&doi=10.1038%2Fs41467-017-02358-7&volume=8&publication_year=2017&author=Bertrand%2CF&author=Montfort%2CA&author=Marcheteau%2CE&author=Imbert%2CC&author=Gilhodes%2CJ&author=Filleron%2CT&author=Rochaix%2CP&author=Andrieu-Abadie%2CN&author=Levade%2CT&author=Meyer%2CN?
- Find out how much https://doi.org/10.1038%2Fni.3518 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20natural%20killer%20cells%20in%20cancer%20immunotherapy&journal=Nat%20Immunol&doi=10.1038%2Fni.3518&volume=17&pages=1025-1036&publication_year=2016&author=Guillerey%2CC&author=Huntington%2CND&author=Smyth%2CMJ pull in monthly?
- How much profit does https://doi.org/10.1111%2Fj.1442-2050.2010.01073.x make?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=NK%20cell%20dysfunction%20with%20down-regulated%20CD16%20and%20up-regulated%20CD56%20molecules%20in%20patients%20with%20esophageal%20squamous%20cell%20carcinoma&journal=Dis%20Esophagus&doi=10.1111%2Fj.1442-2050.2010.01073.x&volume=23&pages=675-681&publication_year=2010&author=Watanabe%2CM&author=Kono%2CK&author=Kawaguchi%2CY&author=Mizukami%2CY&author=Mimura%2CK&author=Maruyama%2CT&author=Izawa%2CS&author=Fujii%2CH?
- https://doi.org/10.4049%2Fjimmunol.1301889's financial summary
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=CD56%28bright%29perforin%28low%29%20noncytotoxic%20human%20NK%20cells%20are%20abundant%20in%20both%20healthy%20and%20neoplastic%20solid%20tissues%20and%20recirculate%20to%20secondary%20lymphoid%20organs%20via%20afferent%20lymph&journal=J%20Immunol&doi=10.4049%2Fjimmunol.1301889&volume=192&pages=3805-3815&publication_year=2014&author=Carrega%2CP&author=Bonaccorsi%2CI&author=Carlo%2CE&author=Morandi%2CB&author=Paul%2CP&author=Rizzello%2CV&author=Cipollone%2CG&author=Navarra%2CG&author=Mingari%2CMC&author=Moretta%2CL&author=Ferlazzo%2CG
- https://doi.org/10.1002%2Fcncr.23239's financial summary
- http://scholar.google.com/scholar_lookup?&title=Natural%20killer%20cells%20infiltrating%20human%20nonsmall-cell%20lung%20cancer%20are%20enriched%20in%20CD56%20bright%20CD16%28%E2%88%92%29%20cells%20and%20display%20an%20impaired%20capability%20to%20kill%20tumor%20cells&journal=Cancer&doi=10.1002%2Fcncr.23239&volume=112&pages=863-875&publication_year=2008&author=Carrega%2CP&author=Morandi%2CB&author=Costa%2CR&author=Frumento%2CG&author=Forte%2CG&author=Altavilla%2CG&author=Ratto%2CGB&author=Mingari%2CMC&author=Moretta%2CL&author=Ferlazzo%2CG's financial summary
- What's the total monthly financial gain of https://doi.org/10.1182%2Fblood-2017-07-796342?
- How much income is http://scholar.google.com/scholar_lookup?&title=Immune%20evasion%20via%20PD-1%2FPD-L1%20on%20NK-cells%20and%20monocyte%2Fmacrophages%20is%20more%20prominent%20in%20Hodgkin%20lymphoma%20than%20DLBCL&journal=Blood&doi=10.1182%2Fblood-2017-07-796342&volume=131&issue=16&pages=1809-1819&publication_year=2018&author=Vari%2CF&author=Arpon%2CD&author=Keane%2CC&author=Hertzberg%2CMS&author=Talaulikar%2CD&author=Jain%2CS&author=Cui%2CQ&author=Han%2CE&author=Tobin%2CJ&author=Bird%2CR earning monthly?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20a%20subset%20of%20human%20natural%20killer%20cells%20expressing%20high%20levels%20of%20programmed%20death%201%3A%20a%20phenotypic%20and%20functional%20characterization&journal=J%20Allergy%20Clin%20Immunol&volume=139&issue=335%E2%80%93346&publication_year=2017&author=Pesce%2CS&author=Greppi%2CM&author=Tabellini%2CG&author=Rampinelli%2CF&author=Parolini%2CS&author=Olive%2CD&author=Moretta%2CL&author=Moretta%2CA&author=Marcenaro%2CE?
- https://doi.org/10.1182%2Fblood-2011-11-392951's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=Tim-3%20marks%20human%20natural%20killer%20cell%20maturation%20and%20suppresses%20cell-mediated%20cytotoxicity&journal=Blood&doi=10.1182%2Fblood-2011-11-392951&volume=119&pages=3734-3743&publication_year=2012&author=Ndhlovu%2CLC&author=Lopez-Verges%2CS&author=Barbour%2CJD&author=Jones%2CRB&author=Jha%2CAR&author=Long%2CBR&author=Schoeffler%2CEC&author=Fujita%2CT&author=Nixon%2CDF&author=Lanier%2CLL bring in each month?
- What's the income generated by https://doi.org/10.4049%2Fjimmunol.175.8.5043 each month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Rapid%20production%20of%20TNF-alpha%20following%20TCR%20engagement%20of%20naive%20CD8%20T%20cells&journal=J%20Immunol&doi=10.4049%2Fjimmunol.175.8.5043&volume=175&pages=5043-5049&publication_year=2005&author=Brehm%2CMA&author=Daniels%2CKA&author=Welsh%2CRM make?
- How much does https://doi.org/10.1146%2Fannurev.immunol.19.1.65 make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Noncytolytic%20control%20of%20viral%20infections%20by%20the%20innate%20and%20adaptive%20immune%20response&journal=Annu%20Rev%20Immunol&doi=10.1146%2Fannurev.immunol.19.1.65&volume=19&pages=65-91&publication_year=2001&author=Guidotti%2CLG&author=Chisari%2CFV produce monthly?
- Profit of http://scholar.google.com/scholar_lookup?&title=Cancer-related%20inflammation&journal=J%20Clin%20Immunol&doi=10.1007%2Fs10875-012-9847-0&volume=33&issue=Suppl%201&pages=S79-S84&publication_year=2013&author=Candido%2CJ&author=Hagemann%2CT
- Get to know https://doi.org/10.4049%2Fjimmunol.1300538's earnings
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Phenotype%20and%20function%20of%20T%20cells%20infiltrating%20visceral%20metastases%20from%20gastrointestinal%20cancers%20and%20melanoma%3A%20implications%20for%20adoptive%20cell%20transfer%20therapy&journal=J%20Immunol&doi=10.4049%2Fjimmunol.1300538&volume=191&pages=2217-2225&publication_year=2013&author=Turcotte%2CS&author=Gros%2CA&author=Hogan%2CK&author=Tran%2CE&author=Hinrichs%2CCS&author=Wunderlich%2CJR&author=Dudley%2CME&author=Rosenberg%2CSA bring in?
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-10-4179 produce monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Profound%20coordinated%20alterations%20of%20intratumoral%20NK%20cell%20phenotype%20and%20function%20in%20lung%20carcinoma&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-10-4179&volume=71&pages=5412-5422&publication_year=2011&author=Platonova%2CS&author=Cherfils-Vicini%2CJ&author=Damotte%2CD&author=Crozet%2CL&author=Vieillard%2CV&author=Validire%2CP&author=Andre%2CP&author=Dieu-Nosjean%2CMC&author=Alifano%2CM&author=Regnard%2CJF making per month?
- Financial intake of https://doi.org/10.1158%2F0008-5472.CAN-13-0371
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Immune%20infiltrates%20are%20prognostic%20factors%20in%20localized%20gastrointestinal%20stromal%20tumors&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-0371&volume=73&pages=3499-3510&publication_year=2013&author=Rusakiewicz%2CS&author=Semeraro%2CM&author=Sarabi%2CM&author=Desbois%2CM&author=Locher%2CC&author=Mendez%2CR&author=Vimond%2CN&author=Concha%2CA&author=Garrido%2CF&author=Isambert%2CN?
- How much does https://doi.org/10.1172%2FJCI45816 net monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Human%20breast%20cancer%20cells%20enhance%20self%20tolerance%20by%20promoting%20evasion%20from%20NK%20cell%20antitumor%20immunity&journal=J%20Clin%20Invest&doi=10.1172%2FJCI45816&volume=121&pages=3609-3622&publication_year=2011&author=Mamessier%2CE&author=Sylvain%2CA&author=Thibult%2CML&author=Houvenaeghel%2CG&author=Jacquemier%2CJ&author=Castellano%2CR&author=Goncalves%2CA&author=Andre%2CP&author=Romagne%2CF&author=Thibault%2CG earns monthly
- How much does https://doi.org/10.1182%2Fblood-2005-08-027979 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Deficient%20expression%20of%20NCR%20in%20NK%20cells%20from%20acute%20myeloid%20leukemia%3A%20evolution%20during%20leukemia%20treatment%20and%20impact%20of%20leukemia%20cells%20in%20NCRdull%20phenotype%20induction&journal=Blood&doi=10.1182%2Fblood-2005-08-027979&volume=109&pages=323-330&publication_year=2007&author=Fauriat%2CC&author=Just-Landi%2CS&author=Mallet%2CF&author=Arnoulet%2CC&author=Sainty%2CD&author=Olive%2CD&author=Costello%2CRT rake in every month?
- How much profit does https://doi.org/10.18632%2Foncotarget.3965 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Highly%20effective%20NK%20cells%20are%20associated%20with%20good%20prognosis%20in%20patients%20with%20metastatic%20prostate%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.3965&volume=6&pages=14360-14373&publication_year=2015&author=Pasero%2CC&author=Gravis%2CG&author=Granjeaud%2CS&author=Guerin%2CM&author=Thomassin-Piana%2CJ&author=Rocchi%2CP&author=Salem%2CN&author=Walz%2CJ&author=Moretta%2CA&author=Olive%2CD generate?
- How much cash flow does https://citation-needed.springer.com/v2/references/10.1186/s12967-019-1917-0?format=refman&flavour=references have monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yujia%20Zheng earn?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yujia%20Zheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu%20Li bring in each month?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jingyao%20Lian makes per month
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jingyao%20Lian%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huiyun%20Yang?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huiyun%20Yang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feng%20Li?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feng%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Song%20Zhao earns monthly
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Song%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu%20Qi?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu%20Qi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yi%20Zhang
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yi%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lan%20Huang each month?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lan%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://static-content.springer.com/esm/art%3A10.1186%2Fs12967-019-1917-0/MediaObjects/12967_2019_1917_MOESM1_ESM.docx make?
- What's the total monthly financial gain of http://creativecommons.org/licenses/by/4.0/?
- What's the monthly income of http://creativecommons.org/publicdomain/zero/1.0/?
- See how much https://s100.copyright.com/AppDispatchServlet?title=TNF-%CE%B1-induced%20Tim-3%20expression%20marks%20the%20dysfunction%20of%20infiltrating%20natural%20killer%20cells%20in%20human%20esophageal%20cancer&author=Yujia%20Zheng%20et%20al&contentID=10.1186%2Fs12967-019-1917-0©right=The%20Author%28s%29&publication=1479-5876&publicationDate=2019-05-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 makes per month
- https://crossmark.crossref.org/dialog/?doi=10.1186/s12967-019-1917-0 income
- How much profit does https://citation-needed.springer.com/v2/references/10.1186/s12967-019-1917-0?format=refman&flavour=citation make?
- Income figures for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- https://www.springernature.com/gp/products's financial summary
- How much cash flow does https://www.springernature.com/gp/librarians have monthly?
- See how much https://www.springernature.com/gp/societies makes per month
- How much profit is https://www.springernature.com/gp/partners making per month?
- What's the monthly income of https://www.springer.com/?
- How much money does https://www.nature.com/ generate?
- How much does https://www.biomedcentral.com/ generate monthly?
- What's the financial intake of https://www.palgrave.com/?
- How much does https://www.apress.com/ generate monthly?
- Find out how much https://www.springernature.com/gp/legal/ccpa earns monthly
- How much revenue does https://www.springernature.com/gp/info/accessibility generate?
- How much does https://support.springernature.com/en/support/home pull in monthly?
- What's the monthly income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much does https://www.springernature.com/ pull in?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref